A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome
Số trang: 8
Loại file: pdf
Dung lượng: 347.36 KB
Lượt xem: 9
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The tissue factor (TF)-dependent extrinsic pathway has been suggested to be a central mechanism by which the coagulation cascade is locally activated in the lungs of patients with acute lung injury and acute respiratory distress syndrome (ALI/ARDS) and thus represents an attractive target for therapeutic intervention.
Nội dung trích xuất từ tài liệu:
A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome
Nội dung trích xuất từ tài liệu:
A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome
Tìm kiếm theo từ khóa liên quan:
BMC Pulmonary Medicine Tissue factor Acute lung injury Acute respiratory distress syndrome Clinical trial Phase IGợi ý tài liệu liên quan:
-
Efect of periodontal therapy on COPD outcomes: A systematic review
16 trang 16 0 0 -
7 trang 15 0 0
-
11 trang 15 0 0
-
8 trang 14 0 0
-
A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis
12 trang 14 0 0 -
7 trang 14 0 0
-
10 trang 14 0 0
-
6 trang 13 0 0
-
Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD
8 trang 13 0 0 -
10 trang 13 0 0